Agreement between predicted risk and prevalence of Down syndrome in first trimester nuchal translucency screening

被引:12
|
作者
Prefumo, F [1 ]
Thilaganathan, B [1 ]
机构
[1] St George Hosp, Sch Med, Fetal Med Unit, Dept Obstet & Gynaecol, London SW17 ORE, England
关键词
Down syndrome; prenatal screening; nuchal translucency; first trimester; validation;
D O I
10.1002/pd.432
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The agreement between predicted risks of Down syndrome and observed prevalence was investigated in a population of 11847 singleton pregnancies screened by first trimester nuchal translucency at a single institution. Twenty-seven cases of Down syndrome were observed; 20 were detected prenatally by nuchal translucency and maternal age screening, three by other means and four postnatally. The screened women were grouped according to their predicted risk of having an affected pregnancy, and this was compared with the observed prevalence. A significant correlation between predicted and observed prevalences was noted, thus demonstrating that risk estimates for Down syndrome based on first trimester nuchal translucency screening are accurate. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:917 / 918
页数:2
相关论文
共 50 条
  • [21] Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
    Thilaganathan, B
    Slack, A
    Wathen, NC
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1997, 10 (04) : 261 - 264
  • [22] First-trimester screening for Down syndrome in France combining fetal nuchal translucency measurement and biochemical markers
    Muller, F
    Benattar, C
    Audibert, F
    Roussel, N
    Dreux, S
    Cuckle, H
    PRENATAL DIAGNOSIS, 2003, 23 (10) : 833 - 836
  • [23] First-trimester nuchal translucency and maternal serum biochemical screening for Down's syndrome: A happy union?
    Thilaganathan, B
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 1999, 13 (04) : 229 - 230
  • [24] The assessment of nuchal translucency and serum markers for down syndrome screening with ductus venosus Doppler measurements in the first trimester
    Ozer, Ozlem
    Sayin, Cenk N.
    Varol, Fusun G.
    JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION, 2010, 11 (04) : 194 - 198
  • [25] First-trimester contingent screening for Down syndrome can reduce the number of nuchal translucency measurements required
    Vadiveloo, Thenmalar
    Crossley, Jennifer A.
    Aitken, David A.
    PRENATAL DIAGNOSIS, 2009, 29 (01) : 79 - 82
  • [27] Model predicted Down syndrome detection rates for nuchal translucency screening in twin pregnancies
    Maymon, Ron
    Rosen, Hadar
    Baruchin, Ohad
    Herman, Arie
    Cuckle, Howard
    PRENATAL DIAGNOSIS, 2011, 31 (05) : 426 - 429
  • [28] First-trimester nuchal translucency screening for fetal aneuploidy
    Sherer, DM
    Manning, FA
    AMERICAN JOURNAL OF PERINATOLOGY, 1999, 16 (03) : 103 - 120
  • [29] Nuchal translucency as a method of first-trimester screening for aneuploidy
    Naidoo, Poovangela
    Erasmus, Ilsa
    Jeebodh, Jayshree
    Nicolaou, Ermos
    van Gelderen, Cyril J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2008, 98 (04): : 295 - 299
  • [30] First-trimester screening for fetal anomalies with nuchal translucency
    OBSTETRICS AND GYNECOLOGY, 1999, 94 (04): : U59 - U60